Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
56.4M
-
Number of holders
-
102
-
Total 13F shares, excl. options
-
56.5M
-
Shares change
-
+1M
-
Total reported value, excl. options
-
$622M
-
Value change
-
+$12.4M
-
Put/Call ratio
-
0.22
-
Number of buys
-
47
-
Number of sells
-
-47
-
Price
-
$11.01
Significant Holders of Astria Therapeutics, Inc. - Common Stock, par value $0.001 per share (ATXS) as of Q3 2024
119 filings reported holding ATXS - Astria Therapeutics, Inc. - Common Stock, par value $0.001 per share as of Q3 2024.
Astria Therapeutics, Inc. - Common Stock, par value $0.001 per share (ATXS) has 102 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 56.5M shares
.
Largest 10 shareholders include FMR LLC (7.82M shares), PERCEPTIVE ADVISORS LLC (6.49M shares), RA CAPITAL MANAGEMENT, L.P. (5.11M shares), Vestal Point Capital, LP (4M shares), Fairmount Funds Management LLC (3.55M shares), BlackRock, Inc. (3.5M shares), VR Adviser, LLC (3.46M shares), TCG Crossover Management, LLC (2.76M shares), VANGUARD GROUP INC (2.64M shares), and MILLENNIUM MANAGEMENT LLC (2.49M shares).
This table shows the top 102 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.